These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1627 related items for PubMed ID: 28600116

  • 41. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery.
    Udelsman BV, Corey KE, Lindvall C, Gee DW, Meireles OR, Hutter MM, Chang DC, Witkowski ER.
    Surg Obes Relat Dis; 2019 Jun; 15(6):843-849. PubMed ID: 31014948
    [Abstract] [Full Text] [Related]

  • 42. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients.
    Rivière B, Jaussent A, Macioce V, Faure S, Builles N, Lefebvre P, Géraud P, Picot MC, Rebuffat S, Renard E, Paradis V, Servais MD, de Preville N, Nocca D, Lajoix AD, Pageaux GP, Galtier F, COMET study group.
    Diabetes Metab; 2022 Jul; 48(4):101345. PubMed ID: 35339664
    [Abstract] [Full Text] [Related]

  • 43. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity.
    Li YJ, Baumert BO, Stratakis N, Goodrich JA, Wu HT, He JX, Zhao YQ, Aung MT, Wang HX, Eckel SP, Walker DI, Valvi D, La Merrill MA, Ryder JR, Inge TH, Jenkins T, Sisley S, Kohli R, Xanthakos SA, Baccarelli AA, McConnell R, Conti DV, Chatzi L.
    World J Gastroenterol; 2024 Jan 28; 30(4):332-345. PubMed ID: 38313232
    [Abstract] [Full Text] [Related]

  • 44. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ, Burton PR, Bayliss J, Raajendiran A, Earnest A, Laurie C, Kemp WW, McLean CA, Roberts SK, Watt MJ, Brown WA.
    Obes Surg; 2019 Jan 28; 29(1):99-108. PubMed ID: 30229460
    [Abstract] [Full Text] [Related]

  • 45. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.
    D'Incao RB, Tovo CV, Mattevi VS, Borges DO, Ulbrich JM, Coral GP, Ramos MJ, Meinhardt NG.
    Obes Surg; 2017 Aug 28; 27(8):2151-2158. PubMed ID: 28281237
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
    Chang EJ, Yi DY, Yang HR.
    J Korean Med Sci; 2015 Dec 28; 30(12):1821-7. PubMed ID: 26713058
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
    Peng L, Wu S, Zhou N, Zhu S, Liu Q, Li X.
    BMC Pediatr; 2021 Mar 12; 21(1):122. PubMed ID: 33711964
    [Abstract] [Full Text] [Related]

  • 52. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery.
    Chisholm J, Seki Y, Toouli J, Stahl J, Collins J, Kow L.
    Surg Obes Relat Dis; 2012 Mar 12; 8(4):416-22. PubMed ID: 21865094
    [Abstract] [Full Text] [Related]

  • 53. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS, Helzberg JH, Nachnani JS, Gurram K.
    Surg Obes Relat Dis; 2008 Mar 12; 4(5):612-7. PubMed ID: 18226970
    [Abstract] [Full Text] [Related]

  • 54. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.
    Morita S, Neto Dde S, Morita FH, Morita NK, Lobo SM.
    Obes Surg; 2015 Dec 12; 25(12):2335-43. PubMed ID: 25920616
    [Abstract] [Full Text] [Related]

  • 55. [Nonalcoholic fatty liver disease: clinical and histological characteristics in obese who underwent bariatric surgery].
    Bitencourt AG, Cotrim HP, Alves E, Almeida AM, Barbosa DB, Santos AS, Lobo AP, Athayde LG, Rios A, Gouveia M, Freitas LA.
    Acta Gastroenterol Latinoam; 2007 Dec 12; 37(4):224-30. PubMed ID: 18254260
    [Abstract] [Full Text] [Related]

  • 56. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
    Poljo A, Kopf S, Sulaj A, Roessler S, Albrecht T, Goeppert B, Bojko S, Müller-Stich BP, Billeter AT.
    Surg Obes Relat Dis; 2023 Dec 12; 19(12):1421-1434. PubMed ID: 37666725
    [Abstract] [Full Text] [Related]

  • 57. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy.
    Algooneh A, Almazeedi S, Al-Sabah S, Ahmed M, Othman F.
    Surg Endosc; 2016 May 12; 30(5):1983-7. PubMed ID: 26194256
    [Abstract] [Full Text] [Related]

  • 58. Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients.
    Billeter AT, Wloka S, Behnisch R, Albrecht T, Roessler S, Goeppert B, Mueller S, Nickel F, Müller B.
    Obes Facts; 2021 May 12; 14(5):490-500. PubMed ID: 34419953
    [Abstract] [Full Text] [Related]

  • 59. Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese.
    Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, Cowley MA, Roberts SK, Kemp W, O'Brien PE, Brown WA.
    Obes Surg; 2017 Jan 12; 27(1):115-125. PubMed ID: 27220852
    [Abstract] [Full Text] [Related]

  • 60. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C, Riquelme A, Ibañez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, Arrese M.
    Obes Surg; 2005 Sep 12; 15(8):1148-53. PubMed ID: 16197788
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 82.